The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 10, 2026

Filed:

Jul. 09, 2021
Applicants:

Institut Pasteur, Paris, FR;

Mcmaster University, Hamilton, CA;

Inventors:

Lida Katsimpardi, Paris, FR;

Pierre-Marie Lledo, Paris, FR;

Bianca Wollenhaupt De Aguiar, Brantford, CA;

Taiane De Azevedo Cardoso, Hamilton, CA;

Flavio Kapczinski, Hamilton, CA;

Bianca Pfaffenseller, Hamilton, CA;

Assignees:

INSTITUT PASTEUR, Paris, FR;

MCMASTER UNIVERSITY, Hamilton, CA;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/18 (2006.01); A61P 25/24 (2006.01); C07K 16/22 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1841 (2013.01); A61P 25/24 (2018.01); C07K 16/22 (2013.01); G01N 33/6896 (2013.01); G01N 2800/304 (2013.01);
Abstract

Provided are methods for the detection of GDF11 in a subject having or suspected of having a mood and/or anxiety disorder, comprising providing a sample from a subject having or suspected of having a mood and/or anxiety disorder; contacting the sample with a GDF11-binding molecule; and detecting bound GDF11. Also provided are methods of diagnosing or characterizing a mood and/or anxiety disorder in a subject, comprising providing a sample from a subject; contacting the sample with a GDF11-binding molecule; detecting bound GDF11; and comparing the levels of detected bound GDF11 to healthy reference levels. Also provided are methods of treating or preventing a mood and/or anxiety disorder and/or accelerated aging in a subject in need thereof, comprising administering to the subject an agent or composition which increases the levels of GDF11 polypeptide in the subject.


Find Patent Forward Citations

Quick Actions:

Katsimpardi, Lida. (2026). Use of gdf11 to diagnose and treat anxiety and depression (U.S. Patent No. 12788798). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12788798

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…